Namwiwat Medical Corporation Public Company Limited Proposes Dividend for the Year 2023, Payable on 17 May 2024 - Marketscreener.com

NAM Stock   4.72  0.18  3.96%   
About 55% of Namwiwat Medical's institutional investors are presently thinking to get in. The analysis of current outlook of investing in Namwiwat Medical suggests that some traders are interested regarding Namwiwat Medical's prospects. Namwiwat Medical's investing sentiment shows overall attitude of investors towards Namwiwat Medical.
  
Namwiwat Medical Corporation Public Company Limited Proposes Dividend for the Year 2023, Payable on 17 May 2024 Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Namwiwat Medical Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Namwiwat Medical stock to make a market-neutral strategy. Peer analysis of Namwiwat Medical could also be used in its relative valuation, which is a method of valuing Namwiwat Medical by comparing valuation metrics with similar companies.